EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Regulatory Role of Iron Transporter SLC39A13 in Liver Fibrosis

Shanshan Guo, Yalin Wang, Binyu Lu, Yu Zhang, David M Frazer, Bing Zhou iD

Advanced Science · 2026

DOI: 10.1002/advs.202516446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Shanshan Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen, China. Hauptthemen laut MEDLINE: Cation Transport Proteins, Liver Cirrhosis, Iron. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Medical Research Fund, Guangdong Provincial Key Laboratory of Synthetic Genomics, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, driven by excessive collagen synthesis following hepatic injury, poses a significant health challenge. SLC39A13/ZIP13, a recently characterized intracellular iron transporter, is shown to provide iron to the ER/Golgi to help catalyze procollagen hydroxylation during collagen maturation. Here, we investigate whether ZIP13 plays a role during hepatic fibrogenesis modeled by CCl 4 stress or other inducers. ZIP13 expression is induced during liver fibrosis. Germline disruption of Zip13 dramatically reduces fibrosis. Surprisingly, these mice do not benefit from ZIP13 loss after CCl 4 challenge; instead, they are more susceptible to CCl 4 toxicity even with substantially less fibrosis development. This elevated vulnerability turns out to be a consequence of ferroptosis in the hepatocyte due to increased cytosolic iron after ZIP13 loss. Tissue‐specific knockout (KO) reveals that hepatic stellate cell (HSC) KO of Zip13 attenuates liver fibrosis progression without adverse effects. Leveraging these findings, HSC‐targeted delivery of Zip13 ‐siRNA demonstrates robust efficacy and safety in preclinical fibrosis models. These results provide critical insights into the complex role of iron in liver fibrosis, and indicate that targeting iron homeostasis via ZIP13 in the HSC may be effective to mitigate fibrogenesis by simultaneously suppressing the synthesis of multiple kinds of collagen while minimizing possible side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cation Transport ProteinsLiver CirrhosisIronAnimalsMiceMice, KnockoutHepatic Stellate CellsDisease Models, AnimalLiverMaleCollagen

Stichwörter der Autor:innen

SLC39A13 (ZIP13)VA‐lip‐siRNAcollagenhepatic stellate cellsironliver fibrosis

Substanzen

Cation Transport ProteinsIronSlc39a13 protein, mouseCollagen

Autor:innen und Institutionen

  • Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen, China.
  • Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Molecular Nutrition Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.

ORCID-Profile: Bing Zhou

Förderung

  • Shenzhen Medical Research Fund
  • Guangdong Provincial Key Laboratory of Synthetic Genomics
  • China Postdoctoral Science Foundation

Zitieren

APA

Guo, S., Wang, Y., Lu, B., Zhang, Y., Frazer, D. M., & Zhou, B. (2026). The Regulatory Role of Iron Transporter SLC39A13 in Liver Fibrosis. Advanced Science. https://doi.org/10.1002/advs.202516446

Vancouver

Guo S, Wang Y, Lu B, Zhang Y, Frazer DM, Zhou B. The Regulatory Role of Iron Transporter SLC39A13 in Liver Fibrosis. Advanced Science. 2026. doi:10.1002/advs.202516446

BibTeX
@article{Guo2026,
  author = {Guo, Shanshan and Wang, Yalin and Lu, Binyu and Zhang, Yu and Frazer, David M and Zhou, Bing},
  title = {The Regulatory Role of Iron Transporter SLC39A13 in Liver Fibrosis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202516446}
}
Kostenlos starten →